Anti-MOG autoantibody-associated schizophreniform psychosis

Acta Neuropsychiatr. 2022 Feb;34(1):47-54. doi: 10.1017/neu.2021.29. Epub 2021 Sep 8.

Abstract

Objectives: Autoimmune mechanisms are related to disease development in a subgroup of patients with psychosis. The contribution of immunoglobulin G (IgG) antibodies against myelin oligodendrocyte glycoprotein (MOG) is mainly unclear in this context.

Methods: Therefore, two patients with psychosis and anti-MOG antibodies - detected in fixed cell-based and live cell-based assays - are presented.

Results: Patient 1 suffered from late-onset psychosis with singular white matter lesions in magnetic resonance imaging (MRI) and intermittent electroencephalography (EEG) slowing. Patient 2 suffered from a chronic paranoid-hallucinatory disorder with intermittent confusional states, non-specific white matter alterations on MRI, a disorganised alpha rhythm on EEG, and elevated cerebrospinal fluid protein. Both patients had anti-MOG antibody titres of 1 : 320 in serum (reference < 1 : 20).

Conclusions: The arguments for and against a causal role for anti-MOG antibodies are discussed. The antibodies could be relevant, but due to moderate titres, they may have caused a rather 'subtle clinical picture' consisting of psychosis instead of 'classical' MOG encephalomyelitis.

Keywords: MOG; MOG encephalomyelitis; autoimmune encephalitis; autoimmune psychosis.

Publication types

  • Case Reports

MeSH terms

  • Autoantibodies*
  • Encephalomyelitis*
  • Humans
  • Magnetic Resonance Imaging
  • Myelin-Oligodendrocyte Glycoprotein* / immunology
  • Psychotic Disorders*

Substances

  • Autoantibodies
  • MOG protein, human
  • Myelin-Oligodendrocyte Glycoprotein